tirzepatide injection results weight loss progress photos Tirzepatide Weight Loss Before and

The results are slightly lower but still clinically significant for most patients

The Medicines and Healthcare products Regulatory Agency (MHRA) advises discontinuing these GLP-1 receptor agonists if pregnancy is planned or confirmed

Tirzepatide (Mounjaro): Targets both GLP-1 and GIP receptors, which can lead to more robust results

Our patients may experience symptoms such as nausea, vomiting, diarrhea, decreased appetite, or constipation, especially in the first weeks of therapy

Ensure adequate calcium and vitamin D intake

Addressing Serious Side Effects Serious side effects like thyroid tumors or diabetic retinopathy are rare, but they need urgent medical help